Traditional host biomarkers such as C-reactive Protein (CRP) or procalcitonin (PCT) are of limited use in the setting of surgery induced inflammatory response, drug- or surgery-induced immunodeficiency, underlying malignancy or high levels of multimorbidity. The gene discussed is CRP; the disease is immunodeficiency disease.